Once the patent is granted, it is expected to last through 2031, according to the report. The company plans to file for CE marking later this year. Clinical trials for FDA approval will be initiated in 2016.
More articles on gastroenterology:
7 things for gastroenterologists to know for today – April 24, 2015
4 GI physicians making headlines – April 24, 2015
Expanding services: The best ancillary lines for GI practices to consider in 2015
